Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PO-0656: Reirradiation+hyperthermia after surgery for recurrent breast cancer: 70% 5-year local control

Autor: Oldenborg, S., Crezee, J., Kusumanto, Y., Van Os, R., Oei, S., Venselaar, J., Zum Vörde Sive Vörding, P., Rasch, C., Van Tienhoven, T.

Publikováno v: In Radiotherapy and Oncology May 2017 123 Supplement 1:S342-S343

The complex between urokinase plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) denotes poor disease outcome in 576 node-negative breast cancer patients

Autor: Manders, P, Beex, L, Tjan-Heijnen, V, Span, P, Grebenchtchikow, N, Geurts-Moespot, J, van Tienhoven, T, Sweep, C

Publikováno v: In EJC Supplements 2004 2(3):173-173

Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.

Autor: Qu S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Trapman-Jansen AMAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Broeren-Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Prager-van der Smissen WJC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., El Hassnaoui H; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., van Tienhoven T; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Bes-Stobbe CK; Pathan BV, Kleiweg 500, 3045 PM Rotterdam, The Netherlands., Westenend PJ; Laboratory of Pathology, 3318 AL Dordrecht, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2023 Dec 20; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 20.